 |
|
Patients with head and neck cancer may have impairment of some driving skills
September 18, 2007A preliminary study suggests that patients with cancer in the head and neck region may have inferior performance in some driving skills compared with individuals without the disease, according to a report in the September issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals.
"Driving is a complex task that requires adequate cognitive, psychomotor and visuoperceptualmotor functions that work together. These functions can be compromised to a greater or lesser extent in patients with cancer in the head and neck region who have received cancer treatment," the authors write. Side effects from cancer treatment may reduce head and neck mobility and may cause cognitive impairment, pain and psychological distress predisposing patients to greater driving risks.
Hon K. Yuen, Ph.D., O.T.R./L., of the Medical University of South Carolina, Charleston, and colleagues used a virtual reality driving simulator to evaluate the driving skills of 10 patients with head and neck cancer (average age 56) and 50 members of the community (average age 48). Researchers recorded average speed, average brake reaction time, steering variability (vehicle offset from the center of driving lane in inches), the total number of collisions and the score of the Simulator Driving Performance Scale, which assesses participants' driving behavior and skills including braking properly at intersections, driving within the speed limit, using mirrors properly and staying a safe distance from other vehicles.
The median (midpoint) time between surgery and participation in the study was 26.6 months and the average time between cancer therapy and study participation was 20 months.
The average brake reaction time and steering variability in the patients with cancer group were significantly longer (3,134.92 milliseconds vs. 2,299.8 milliseconds) and larger (271.26 inches vs. 46.45 inches), respectively, than those in the control group. There was not a significant difference between the two groups in average speed (21.8 miles per hour vs. 25.18 miles per hour), total number of collisions (1.1 vs. 1.4) or Simulator Driving Performance Scale scores.
"This pilot study provides preliminary evidence indicating inferior driving performance in a group of patients with cancer in the head and neck region when compared with a community control group," the authors conclude. Further study is needed to investigate specific causes that may contribute to poor driving performance and the consequences this may have on driving in the real world for patients with cancer.
JAMA and Archives Journals
The median (midpoint) time between surgery and participation in the study was 26.6 months and the average time between cancer therapy and study participation was 20 months.
The average brake reaction time and steering variability in the patients with cancer group were significantly longer (3,134.92 milliseconds vs. 2,299.8 milliseconds) and larger (271.26 inches vs. 46.45 inches), respectively, than those in the control group. There was not a significant difference between the two groups in average speed (21.8 miles per hour vs. 25.18 miles per hour), total number of collisions (1.1 vs. 1.4) or Simulator Driving Performance Scale scores.
"This pilot study provides preliminary evidence indicating inferior driving performance in a group of patients with cancer in the head and neck region when compared with a community control group," the authors conclude. Further study is needed to investigate specific causes that may contribute to poor driving performance and the consequences this may have on driving in the real world for patients with cancer.
JAMA and Archives Journals
Neck Cancer Current Events and Neck Cancer News RSSNew platinum-phosphate compounds kill ovarian cancer cells
A new class of compounds called phosphaplatins can effectively kill ovarian, testicular, head and neck cancer cells with potentially less toxicity than conventional drugs, according to a new study published this week in the journal Proceedings of the National Academy of Sciences.
Survival of head and neck cancer patients is greatly affected by coexisting ailments
Current estimates for head and neck cancer survival are largely inaccurate because they widely disregard many of the most common diseases such patients have in addition to their primary cancer, says Jay Piccirillo, M.D., a head and neck specialist at Washington University School of Medicine in St. Louis, the Siteman Cancer Center and Barnes-Jewish Hospital.
Oral rinses used for tracking HPV-positive head and neck cancers holds promise for cancer screening
A study published in the journal Clinical Cancer Research, a journal of the American Association for Cancer Research, validates a non-invasive screening method with future potential for detection of human papillomavirus (HPV)-positive head and neck cancers.
News from Cancer: Disparities in head and neck cancer patients
A new analysis finds considerable disparities in survival related to race and socio-economic status among patients with head and neck cancer.
Joining forces against cancer
In cancer therapy, the best results are often achieved by combining treatments such as chemotherapy, radiotherapy and surgery.
As head and neck cancer risks evolve, more treatment options emerge
Advances in understanding head and neck cancer over the last decade have led to more treatment options and improved quality of life for patients, according to a review published this week in the New England Journal of Medicine.
Acupuncture reduces pain and dysfunction in head and neck cancer patients after neck dissection
New data from a randomized, controlled trial found that acupuncture provided significant reductions in pain, dysfunction, and dry mouth in head and neck cancer patients after neck dissection.
Quality of life predicts cancer survival, U-M study finds
Head and neck cancer patients who reported lower physical quality of life were more likely to die from their disease, according to a new study from the University of Michigan Comprehensive Cancer Center.
Gene therapy increases survival for end-stage head and neck cancer
A gene therapy invented at The University of Texas M. D. Anderson Cancer Center is the first to succeed in a U.S. phase III clinical trial for cancer, as announced today at the American Society of Gene Therapy annual meeting in Boston.
JAMA publication features UNMC study on depression and head and neck cancer
A University of Nebraska Medical Center-led pilot study that showed antidepressants can significantly reduce the risk of depression for head and neck cancer patients is the focus of an article published today in the Archives of Otolaryngolgy -- one of the publications produced by the Journal of American Medical Association (JAMA).
More Neck Cancer Current Events and Neck Cancer News Articles
 | Head and Neck Cancer: A Multidisciplinary Approach (Head and Neck Cancer) This book employs a two-part approach to treating patients with head and neck cancer: maximize the chance for a cure while maintaining a strong emphasis on quality of life. Although not seen as commonly as other aggressive forms, head and neck cancer is a devastating disease that has tremendous implications on the overall health of the patient, as well as their appearance and quality of life. The... |
 | 100 Q&A About Head and Neck Cancer (100 Questions & Answers about . . .) (100 Questions & Answers) by Elise Carper Tumors of the head and neck afflict nearly forty thousand people annually and account for approximately five percent of all cancers. Whether you're a newly diagnosed head and neck cancer patient, a survivor, or friend or relative of either, this book offers help. The only text to provide the doctor's and patient's views, 100 Questions & Answers About Head and Neck Cancer gives you authoritative,... |
| Meeting the Challenges of Oral and Head and Neck Cancer: A Survivor's Guide Nancy Leupold, herself a survivor, and president and founder of Support for People with Oral and Head and Neck Cancer (SPOHNC), and James J. Sciubba present an overview of the different disciplines involved in the treatment of oral and head and neck cancer, with emphasis on providing information and survivor tips to help survivors cope with the disease, its treatment, and their consequential side... | |
 | Head and Neck Cancer Imaging (Medical Radiology / Diagnostic Imaging) This book provides a comprehensive review of state-of-the-art imaging in head and neck cancer. Precise determination of tumor extent is of the utmost importance in these neoplasms, as it has important consequences for staging of disease, prediction of outcome and choice of treatment. Only the radiologist can fully appreciate submucosal, perineural, and perivascular tumor spread and detect... |
 | Head and Neck Cancer: An Evidence-Based Team Approach by Eric Genden, Mark Varvares Recent treatments and management styles have created the need for this new book on this very intractable cancer. The latest surgical, radiation, and chemotherapeutic protocols are presented, approaching each disease process from a multidisciplinary perspective, offering the reader a guide to the diagnosis, initial treatment, adjuvant therapy, supportive therapy, and post-operative... |
 | Squamous Cell Head and Neck Cancer: Recent Clinical Progress and Prospects for the Future (Current Clinical Oncology) Leading expert physicians and investigators from around the world review the state-of-the-art in the management of squamous cell head and neck cancer, with emphasis on coordinating different treatment modalities. The authors address several surgical issues, including laser-based surgery, larynx preservation approaches, salvage surgery, and neck management after non-operative treatment. They also... |
 | Imaging of Head and Neck Cancer This concise integrated handbook looks at all available imaging methods for head and neck cancer, highlighting the strengths and weaknesses of each method. The information is provided in a clinical context and will guide radiologists as to the information the clinician actually needs when managing a patient with head and neck cancer. It will also provide the clinician with the advantages and... |
 | Head and Neck Cancer: Treatment, Rehabilitation, and Outcomes by Elizabeth C. Ward and Corina J. van As Brooks A team of expert authors from the medical and allied health communities describe recent advances in the management of head and neck cancer through a greater understanding of cancer cell growth and mechanisms, as well as the expansion of rehabilitation strategies across the allied health profession. In addition to introducing new information, the book covers both the theoretical and... |
 | Metastases in Head and Neck Cancer The incidence of malignant tumors of the upper aerodigestive tract is increasing. The carcinomas of this area, mostly squamous cell carcinomas, are often accompanied by cervical lymph node metastases. Frequently, the primary tumor causes no discomfort and its existence is inferred from the presence of metastases. The present book offers an extensive overview of the differential diagnosis of... |
| Contemporary Considerations In The Treatment And Rehabilitation Of Head And Neck Cancer: Voice, Speech, And Swallowing This book, while a new text, has its origins in three earlier editions of a previously published book, Laryngectome Rehabilitation, edited by Robert Keith and Frederic L. Darley. This new version of that book provides a broader vision related to concerns influencing rehabilitation in those with head and neck cancer. Numerous and complex issues regarding voice, speech, and swallowing in... |
| © 2008 BrightSurf.com |